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Novelty Statements 
 Hospital service utilizations with respect to hospital admission and emergency 
department visits were significantly reduced after PEP participation in ‘real-world’ 
primary care setting.  
 Our population-based cohort study showed that structured diabetes education program 
led to the benefits of substantial reductions in the initial episode and frequencies of 
hospital service utilizations and their associated direct medical costs. 
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Abstract 
 
Aims: To assess whether a structured diabetes education program, Patient Empowerment 
Programme (PEP), was associated with a lower rate of all-cause hospitalization and 
emergency department (ED) visits in a population-based cohort of type 2 diabetes mellitus 
(T2DM) patients in primary care. 
Methods: A cohort of 24,250 patients was evaluated using linked administrative database 
during 2009-2013. We selected 12,125 T2DM patients who had at least one PEP session 
attendance. Non-PEP participants were matched one-to-one with PEP participants using 
propensity-score method. Episodes of hospitalization and ED visit are the events of interest. 
Cox proportional hazard and Negative binomial regressions were performed to estimate the 
hazard ratios (HR) for initial episode of event, and incidence rate ratios (IRR) for the 
number of event episode, respectively.  
Results: During a median 30.5 months of follow-up, PEP participants had a lower incidence 
of initial episode of hospitalization (22.09% vs 25.19%; HR: 0.879; P<0.001) and ED visit 
(40.49% vs 44.00%; HR: 0.901; P<0.001) than those without PEP. PEP was associated with 
statistically significant decreased number of ED visits (IRR: 0.903; P<0.001), from 40.424 
ED visits per 100 patients annually without PEP to 36.153 per 100 patients annually with 
PEP. There were statistically significant reductions in number of hospitalizations (IRR: 
0.854; P<0.001), from 19.984 hospitalizations per 100 patients annually without PEP to 
16.878 hospitalizations per 100 patients annually with PEP. 
Conclusions: Among T2DM patients, PEP was shown to be effective in delaying the initial 
episode of hospital utilization and reducing their frequencies. 
 
 
Keywords: Hospitalization; Emergency department; type 2 diabetes, Structured education; 
Self management; Primary Care 
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Manuscript Text 
 
Introduction 
 
Diabetes mellitus is one of the commonest chronic diseases experienced by patients treated 
in primary care, and it is highly prevalent chronic disease associated with the development 
of both the mortality and morbidity including diabetes-related complications over the past 
decades.[1] In the US, owing to the substantial rise in the prevalence, diabetes mellitus 
projected to result in 43.1 million hospital inpatient days and 15.3 million times of 
emergency department visits each year.[2] While about one-four of all hospital inpatients 
days were incurred by patients with diabetes and about one-nine of all emergency 
department visits were incurred by patients with diabetes, the annual direct health care 
expenditures of hospitalization and emergency department visits incurred by patients with 
diabetes were projected to exceed 138 billion dollars.[2] Such economic burden of diabetes 
is expected to increase with the aging population worldwide, and underlined the important of 
developing multi-faceted clinical care and effective management strategies to reduce 
consequently preventable hospital service utilizations for patients with diagnosed diabetes.  
 
Currently, structured diabetes education program is one of the key components of a clinical 
care and management strategy for patients with diabetes and those at high risk for 
developing diabetes-related complication.[3] Clinical benefits of structured diabetes 
education program has been well-recognized and confirmed in several systematic reviews[4-
6] and meta-analyses,[7-9] in which thereby theoretically reduce health care expenditures 
and hospital service utilization. Apart from studies in Type 1 diabetes population[10], there 
is mixed and limited evidence on the effects of structured diabetes education program on the 
use of hospital services including avoidable hospitalizations and unfavourable adverse 
events presented at emergency department visits. Most previous studies[11-13] reported the 
one-year effect of the education program on hospital service utilization that were not 
reduced significantly, whereas three studies[14-16] initiating more than one-year horizon 
reported that patients in education group experienced significantly lower frequency of the 
hospital services related to diabetes compared with those without. However, education 
programs delivered in specialist clinics and secondary care might not reflect current ‘real-
world’ practice in primary care setting. In such, limited evidence is available on population-
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based data comparing the utilization rates of hospital service with and without structured 
diabetes education program. 
 
Recent observational matched studies[17-19] addressed the knowledge gaps regarding the 
uncertainties surrounding effectiveness of structured diabetes education program in ‘real-
world’ setting. The Patient Empowerment Programme (PEP) is a structured diabetes 
education program for individuals with type 2 diabetes. Evaluation of PEP in Hong Kong 
has shown to have significant improvement in metabolic control and reduction in the risk of 
cardiovascular diseases and all-cause mortality. Meanwhile, our aim of this population-
based propensity score matched cohort study was to evaluate the influence of PEP 
implemented in primary care on hospital service utilizations as compared to the alternative 
usual clinical practice without PEP. The incidence of emergency department visits and 
hospitalizations over the two years were examined between PEP and the usual clinical 
practice. It was hypothesised that PEP participants would be significantly associated with 
lower risks of initial and multiple episodes of hospital service utilizations. 
 
Methods 
 
The PEP structured education program has been launched by the Hong Kong Hospital 
Authority since 2010. It serves as a component of the multi-faceted management strategy to 
facilitate quality enhancement in primary care setting. It aims at providing participants with 
the knowledge, skills and self-awareness of their own disease condition and promoting 
autonomous self-regulation to maximise their potential for health and well-being. 
Individual’s lifestyle modification and risk factor management can be enhanced through 
different areas such as health education, skill transfer, self-efficacy enhancement, mutual 
support groups in the program. In order to enhance and maintain the participants’ self-
management, 6-8 sessions on disease-specific knowledge and self-management skills, self-
efficacy and lifestyle modification and post-program follow-ups were delivered by the 
expertise in community medical service and education of the non-government organisations. 
The detailed description of PEP setting and mode of education delivery has been reported 
previously[17-19].  
 
Subjects 
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As of 31 March, 2012, the PEP has now been delivered to 15,497 adults with T2DM 
through four non-government organizations in Hong Kong. Informed consent was 
obtained from all individual participants included in the study. All subjects with T2DM 
who had attended at least one PEP session were included in the outcome evaluation from a 
population-based cohort through the clinical management system administrative database 
of Hong Kong Hospital Authority which is the largest and sole public health service 
provider in Hong Kong. T2DM subjects were identified with the International 
Classification of Primary Care-2 (ICPC-2) code of ‘T90’, through the administrative 
database of Hong Kong Hospital Authority. This study included patients attended at least 
one session of PEP on a date from 1 March, 2010 to 30 June, 2012. Each patient was 
observed from baseline date to whichever following event came first until 31 Dec 2013 i.e. 
the date of death, or last follow-up as censoring. The first date of PEP session attendance 
was regarded as baseline data. 
 
To assess the net effect of PEP on post-intervention, the same number of 172,448 T2DM 
patients who had not ever participated in PEP on or before 31 Dec 2013 were matched to 
PEP subjects on propensity score matching by summarising the baseline covariates as the 
non-PEP group described as below. The subjects were defined as having history of co-
morbidities and diagnosis of diabetes-related complications according to the diagnosis 
coding system of International Classification of Diseases, Ninth Edition, Clinical 
Modification (ICD-9-CM) in administrative database of the Hong Kong Hospital 
Authority. The use of ICD-9-CM diagnosis coding systems were managed to capture the 
history of co-morbidities and diagnosis of diabetes-related complications in hospital care 
settings. Treatment modality, duration of T2DM, history of hypertension and family 
history of T2DM was retrieved from Diabetes Mellitus Complication Screening module of 
clinical management system database. 
 
Baseline Covariates 
 
Covariates of patients included the collection of socio-demographic, biomedical data and 
disease characteristics, and treatment modalities and enrolment of co-intervention[20, 21] 
for diabetes at baseline. Socio-demographic characteristics of patients included sex (female; 
male), age, smoking status (non-smoker; smoker), alcohol status (non-drinker; drinker), and 
educational level (no formal education/primary; secondary/tertiary). Biomedical data 
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consisted of body mass index (BMI), Haemoglobin A1c (HbA1c), blood pressure, lipid 
profile, triglyceride and estimated glomerular filtration rate (eGFR) on the date within six-
month period of baseline date. Disease characteristics included duration of T2DM (≤5 
years; 5-10 years; >10 years), history of hypertension, history of macrovascular 
complication (including coronary heart disease, stroke, heart failure), history of 
microvascular complication (including retinopathy, nephropathy and neuropathy), family 
history of T2DM (yes; no; unknown), and number of severe hypoglycaemic events (0; 1; 
≥2).  
 
Propensity Score Matching 
 
A propensity score matching was first introduced in 1983 [22] as the conditional probability 
of being intervention given the observed covariates[23]. The key purpose in this study was to 
create equivalent PEP intervention and non-PEP comparison groups by logistic regression 
analysis with summarising relevant baseline characteristics of each patient into a single-index 
variable (the propensity score) and then matching patients in the non-PEP pool to the patients 
in PEP intervention group based on the value of the propensity score [22, 24, 25]. 
Correspondingly, the propensity score was generated for each patient, modelling PEP 
intervention as a dependent variable while the baseline covariates (including sex, age, 
smoking status, alcohol status, educational level, HbA1c level, BMI, blood pressure, 
triglyceride, total cholesterol-to-high density lipoprotein cholesterol ratio, low density 
lipoprotein cholesterol, eGFR, duration of T2DM, history of hypertension, history of 
macrovascular complication, history of microvascular complication, family history of 
diabetes mellitus, the use of insulin and enrolment of co-intervention for diabetes) of patients 
as independent variables. The propensity score mapping was made by using the “psmatch2” 
command[26] with one-to-one matching without replacement method in the STATA.  
 
Data Analysis 
 
Descriptive statistics for the baseline characteristics of socio-demographic and clinical 
data in PEP and non-PEP groups were calculated after propensity score matching, and 
their differences were tested using Chi-square test or independent t-test for continuous or 
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categorical variables, respectively. Episodes of hospitalization and emergency department 
visit are the outcome events of interest. The cumulative incidence rate and incidence rate 
of outcome events with 95% confidence interval based on the assumption that the 
observed incident cases followed a Poisson distribution in PEP and non-PEP groups were 
reported.  
 
Multivariable Cox proportional hazards regression was performed to estimate the effect of 
PEP on the initial episode of outcome events, accounting for all baseline characteristics of 
patients. For each event model, survival curves were estimated by Kaplan-Meier method 
and their differences between PEP and non-PEP groups were compared using the log-rank 
test. Hazard ratio (HR) with 95% confidence intervals was reported for each factor in the 
regression models. Predictive accuracy of Cox models was assessed and compared using 
Harrell’s discrimination C-index, ranging from zero to one. A value of 0.5 indicates no 
predictive discrimination, and values of 0 or 1.0 indicate perfect separation of patients[27]. 
Goodness-of-fit for Cox regression model were assessed using Akaike information 
criterion (AIC) and Bayesian information criterion (BIC).  
 
Frequencies of outcome events were compared between the PEP and non-PEP groups by 
Poisson regression analyses when adjusted all baseline characteristics of patients. Negative 
binomial regression models were used instead of Poisson regression models in cases when 
the ratio of residual deviance to degrees of freedom was far greater than one, indicating the 
overdispersed count outcomes. 
 
In addition to intention to treat analysis, per protocol analysis was also performed using 
PEP participants who had completed the program and the propensity-matched non-PEP 
participants. All statistical analyses were performed using STATA Version 13.0 
(StataCorp LP. College Station, Texas, U.S.). All significance tests were two-tailed and 
those with a p-value less than 0.05 were considered statistically significant. 
 
Ethics approval of this study was granted by Institutional Review Board in Hong Kong, 
and international clinical trial registry (NCT01935349, ClinicalTrials.gov). 
 
Results 
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Socio-demographic, baseline laboratory results and clinical characteristics of both PEP 
and non-PEP participants after propensity score matching are displayed in Table 1. Out of 
a total of 15,497 T2DM subjects, 12,125 (78.2%) were successfully matched with non-
PEP participants by socio-demographic and clinical characteristics. Both groups had 
similar socio-demographic and clinical characteristics, as reflected by p-values all greater 
than 0.05. Moreover, 6,099 PEP participants who completed the programme were also 
paired with non-PEP participants on a one-to-one basis for sensitivity analysis. These two 
groups also showed insignificant difference in all socio-demographic and baseline 
characteristics. 
 
Figure 1 and Table 2 show the Kaplan-Meier survival curves and the incidence rates of all-
cause hospitalization and emergency department visit. PEP participants had fewer 
numbers of all-cause hospitalization. After a median follow-up period of 30.5 months, 
5,733 cases of all-cause hospitalization (2,679 PEP participants and 3,054 non-PEP 
participants) occurred during a total of 27,625 person-years for PEP participants and 
27,217 person-years for non-PEP participants. Similar findings were observed for event of 
emergency department visit. During a median 26.5 months of follow-up and a total of 
23,882 person-years for PEP participants and 23,369 person-years for non-PEP 
participants, only 4,909 incidences were resulted for PEP participants compared with 
5,335 incidences for non-PEP participants. 
 
Multivariable analyses on the dependent variable of all-cause hospitalization and 
emergency department visit are shown in Table 3. After adjusting for the socio-
demographic and clinical characteristics in Cox proportional hazard model, PEP 
participants were associated with a lower risk of all-cause hospitalization (22.09% vs 
25.19%; HR 0.879; 95% CI 0.834-0.926; P<0.001) than the non-PEP participants. Results 
from log-rank tests also reveal that there was significant difference between groups (chi-
squared = 32.42; P<0.001). Additionally, there was a lower incidence of emergency 
department visit among PEP participants (40.49% vs 44.00%; HR 0.901; 95% CI 0.867-
0.937, P<0.001) than those non-PEP participants and the difference in time to emergency 
department visit was also statistically significant (chi-square test= 27.92; P<0.001). In 
sensitivity analysis, similar results were obtained for PEP participants who completed the 
programme. Lower risks of all-cause hospitalization (23.91% vs 20.56%; HR: 0.835; 95% 
CI 0.773-0.901; P<0.001) and emergency department visit (42.81% vs 39.56%; HR 0.890; 
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95% CI 0.842-0.942; P<0.001) were observed among PEP completer than those without 
PEP. The differences in time to hospitalization were also significant (all-cause 
hospitalization: chi-squared = 26.13; P<0.001, emergency department visit: chi-squared = 
18.38; P<0.001). 
 
For the estimation of incidence rate ratios (IRR) using negative binomial regression model, 
PEP participants was associated with a significant decreased number of all-cause 
hospitalizations (IRR: 0.854; P<0.001), from 19.984 hospitalizations per 100 patients 
annually without PEP to 16.878 hospitalizations per 100 patients annually with PEP. Also, 
the reduction in the number of emergency department visit was highly significant (IRR: 
0.854; P<0.001), from 40.424 visits per 100 patients annually without PEP to 36.153 per 
100 patients annually with PEP. 
 
Discussions 
 
This is the large scale population-based cohort study investigating the associations 
between structured diabetes education program and hospital service utilizations, among 
T2DM patients predominantly treated in primary care setting. In a population-based cohort 
of T2DM patients in primary care setting, our analyses have demonstrated that the 
incidence rates of hospitalization and emergency department visits were reduced by 14.6% 
and 9.7% in a median 2.5 years of follow-up after PEP participation compared to usual 
clinical practice without PEP. The reductions in hospitalization (PEP vs non-PEP: 16.878 
vs 19.984 per 100 person-years) due to education intervention was encouraging although 
the reductions were less promising than those reported in the US Urban Diabetes Study 
(29.12 vs 38.05 per 100 person-years)[16]. Likewise, there were 12.1% and 9.9% 
decreased risk of experiencing an initial episode of hospitalization and emergency 
department visits after PEP participation. One of the plausible explanations was that such 
associations may be attributable to improvement in clinical outcomes and prevention of 
diabetes-related complications, ultimately leading to reductions in hospitalization and 
emergency department visits, although structured diabetes education program acts through 
many pathways to produce the reductions of hospital service utilizations.  
 
More importantly, the population-based data quantified the impact of PEP implementation 
on economic burden of T2DM patients to health care system. Reducing the overall 
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frequencies of hospitalization and emergency department visits due to the PEP 
implementation is projected to save the medical expenditure of at least annual direct 
medical cost of US$34,202 (3.106*$9,200+4.271*$1,318) for each T2DM patient, 
assuming that the standard cost of a hospitalization was US$9200 and cost of an 
emergency department visit was US$1,318 in 2009[28]. As a result of reduced episodes of 
hospital service utilization, we hypothesized the considerable reductions in the direct 
medical costs for health care system but the precise cost of PEP implementation has not 
yet taken into account. More in-depth cost-effectiveness analysis should be conducted to 
calculate the net reduction (or gain) in medical expenditure as a whole, and to provide a 
recommendation of whether the PEP was cost-saving or cost-effective when compared to 
usual clinical practice without PEP. 
 
In our cohort of T2DM population, all-cause hospitalization and emergency department 
visit were frequent and occurred in 23.64% and 42.24% of the population, with incidence 
rates of 18.430 and 38.287 episodes per 100 person-years, respectively. The number of 
T2DM patients having emergency department visit was greater than those having 
hospitalized, whereas the frequency of hospitalization episode was one-time greater than 
that of emergency department visit. The phenomenon was observed in PEP and non-PEP 
participants. Interestingly, hospital readmission and a repeat of emergency department 
visit appeared to be avoidable if the PEP started in T2DM patients. Among those having 
emergency department visit, 2,343 (19.3%) and 2,662 (22.0%) of PEP and non-PEP 
participants recorded a repeat of emergency department visit with any diagnosis. Moreover, 
1,102 (9.1%) and 1,327 (10.9%) of hospitalized PEP and non-PEP participants were 
readmitted with any cause. Perhaps further studies should continue to breakdown the 
detailed principal diagnosis of admissions and visits in hospital care associated with PEP 
intervention to better understand the mechanisms how PEP intervention prevented a repeat 
episode of admission and emergency department visit. One possible mechanism was that 
the association between PEP intervention and hospital service utilizations was likely, in 
part, mediated through changes healthy lifestyle behaviors. PEP intervention promoted 
healthy lifestyle behaviorial changes which conferred beneficial effects on cardiovascular 
diseases[29], and thereby prevention of hospital service episodes.  
 
Finding in current study was in line with three prior studies [14-16] which examined the 
effects of diabetes education program on hospital service utilization over a prolonged 
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follow-up period. First, structured diabetes education group in a Korean study was 
significantly lower frequency of hospitalization related to diabetes than control group after 
a median follow-up of four years. Moreover, results from a retrospective cohort study 
showed that education program was significantly associated with delaying in first episode 
of hospitalization. Conversely, the results from one-year studies[11-13, 18] consistently 
showed that there was no significant difference in the frequency of inpatient visits between 
structured diabetes education and control groups. By contrast with argument that program 
effect deteriorated over time[9], the cumulative effects of PEP on the initial and multiple 
episodes of hospitalization and emergency department visits were recognized in current 
study. 
 
Besides the main analysis using whole group of PEP participants, risks of hospitalization 
and emergency department visits after PEP participation were more pronounced among 
those with program completion at sensitivity analysis. Consistent with our recent work[17, 
18], the program completion strengthened the associations of PEP intervention with 
cardiovascular and microvascular complications, and it enhanced efforts on the 
preventions of diabetes-related complications. In aggregate, our findings clearly supported 
that PEP completers experienced greater benefit from PEP intervention. 
 
Limitations 
 
Several limitations of this study should be acknowledged. First, this is an observational 
database study, subject to the misclassification bias of outcome and comorbidity pre-
defined  by ICD-9-CM coding as well as the selection bias of PEP participants who are 
likely to be motivated and involved in healthy lifestyle modification. Likewise, patients 
who were suffered from multiple chronic conditions may be precluded from PEP 
enrolment but they may have high likelihood of hospital services utilizations. Furthermore, 
the confounding variables such as lifestyle behavior, health literacy and motivation were 
not measurable in administrative database. Nevertheless, the design of propensity score 
matching was conducted to minimize the selection and confounding biases arising from 
the comparative study, and further establish a fair comparisons of outcome events between 
PEP and non-PEP groups. Secondly, unit costs of hospitalization and emergency 
department visit were not stratified by the principal disease diagnosis represented by the 
ICD-9-CM diagnosis code system. For instance, hospital admissions related to 
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macrovascular complications were more costly than that related to microvascular 
complications[30, 31]. Finally, data from this study were not entirely representative of 
Chinese populations in other parts of the world, or those under specialist care or in the 
private sector, even though the findings were generated from a large population-based 
database of the public service that managed over 50% of diabetic patients in Hong Kong. 
 
Conclusion 
 
In conclusion, hospital service utilizations with respect to hospital admission and 
emergency department visits were significantly reduced after PEP participation in ‘real-
world’ primary care setting. Our population-based cohort study also showed that  
structured diabetes education program led to the benefits of substantial reductions in the 
initial episode and frequencies of hospital service utilizations and their associated direct 
medical costs.  
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Table 1. Socio-demographic and clinical characteristics 
 PEP Participants vs non-PEP Participants PEP Completers vs non-PEP Participants 
Factor Total 
(N=24,250) 
% (N) 
PEP (N=12,125) 
% (N) 
Non-PEP 
(N=12,125) 
% (N) 
P-value Total 
(N=12,198) 
% (N) 
PEP (N=6,099) 
% (N) 
Non-PEP 
(N=6,099) 
% (N) 
P-value 
Socio-demographic                 
Sex    0.074    0.419 
 Female 56.8 (13,770) 57.4 (6,954) 56.2 (6,816)  58.4 (7,120) 58.0 (3,538) 58.7 (3,582)  
 Male 43.2 (10,480) 42.6 (5,171) 43.8 (5,309)  41.6 (5,078) 42.0 (2,561) 41.3 (2,517)  
Age (mean±SD), year 63.85±10.67 
(24,250) 
63.84±9.76 
(12,125) 
63.86±11.51 
(12,125) 
0.928 63.89±10.38 
(12,198) 
63.98±9.34 
(6,099) 
63.79±11.32 
(6,099) 
0.321 
Smoking status    0.977    0.616 
 Non-smoker 94.8 (22,989) 94.8 (11,495) 94.8 (11,494)  95.9 (11,697) 95.8 (5,843) 96.0 (5,854)  
 Smoker 5.2 (1,261) 5.2 (630) 5.2 (631)  4.1 (501) 4.2 (256) 4.0 (245)  
Alcohol status    0.237    0.891 
 Non-drinker 80.5 (19,519) 80.8 (9,796) 80.2 (9,723)  80.6 (9,826) 80.6 (4,916) 80.5 (4,910)  
 Drinker 19.5 (4,731) 19.2 (2,329) 19.8 (2,402)  19.4 (2,372) 19.4 (1,183) 19.5 (1,189)  
Educational level    0.335    0.638 
 No formal education/ primary 52.5 (12,739) 52.8 (6,407) 52.2 (6,332)  50.9 (6,212) 51.1 (3,119) 50.7 (3,093)  
 Secondary/ tertiary 47.5 (11,511) 47.2 (5,718) 47.8 (5,793)  49.1 (5,986) 48.9 (2,980) 49.3 (3,006)  
         
Biomedical data at baseline 
(mean±SD) 
        
BMI, kg/m2 25.52±3.94 
(24,250) 
25.51±3.94 
(12,125) 
25.53±3.94 
(12,125) 
0.720 25.38±3.90 
(12,198) 
25.36±3.86 
(6,099) 
25.40±3.93 
(6,099) 
0.621 
HbA1c, % 7.31±1.19 
(24,250) 
7.32±1.16 
(12,125) 
7.31±1.22 
(12,125) 
0.540 7.32±1.19 
(12,198) 
7.32±1.16 
(6,099) 
7.32±1.21 
(6,099) 
0.978 
Systolic blood pressure, mmHg 134.03±17.07 
(24,250) 
134.01±17.94 
(12,125) 
134.05±16.15 
(12,125) 
0.844 134.40±17.06 
(12,198) 
134.51±17.80 
(6,099) 
134.28±16.28 
(6,099) 
0.453 
 PEP Participants vs non-PEP Participants PEP Completers vs non-PEP Participants 
Factor Total 
(N=24,250) 
% (N) 
PEP (N=12,125) 
% (N) 
Non-PEP 
(N=12,125) 
% (N) 
P-value Total 
(N=12,198) 
% (N) 
PEP (N=6,099) 
% (N) 
Non-PEP 
(N=6,099) 
% (N) 
P-value 
Diastolic blood pressure, mmHg 75.25±10.52 
(24,250) 
75.27±10.82 
(12,125) 
75.22±10.22 
(12,125) 
0.723 75.28±10.28 
(12,198) 
75.23±10.51 
(6,099) 
75.33±10.05 
(6,099) 
0.583 
Triglyceride, mmol/L 1.55±0.99 
(24,250) 
1.56±0.93 
(12,125) 
1.54±1.04 
(12,125) 
0.338 1.55±1.00 
(12,198) 
1.56±0.93 
(6,099) 
1.54±1.07 
(6,099) 
0.158 
TC/HDL-C ratio 3.92±1.12 
(24,250) 
3.92±1.14 
(12,125) 
3.91±1.09 
(12,125) 
0.393 3.90±1.14 
(12,198) 
3.91±1.18 
(6,099) 
3.90±1.11 
(6,099) 
0.550 
LDL-C, mmol/L 2.83±0.80 
(24,250) 
2.84±0.80 
(12,125) 
2.83±0.79 
(12,125) 
0.216 2.86±0.81 
(12,198) 
2.86±0.81 
(6,099) 
2.86±0.81 
(6,099) 
0.903 
eGFR, ml/min/1.73m2 84.12±21.53 
(24,250) 
84.33±20.03 
(12,125) 
83.90±22.92 
(12,125) 
0.120 84.82±24.02 
(12,198) 
84.57±19.90 
(6,099) 
85.07±27.53 
(6,099) 
0.254 
         
Clinical         
Duration of T2DM, year 7.27±6.39 
(24,250) 
7.25±6.51 
(12,125) 
7.29±6.27 
(12,125) 
0.642 7.28±6.45 
(12,198) 
7.25±6.58 
(6,099) 
7.30±6.32 
(6,099) 
0.621 
Duration of T2DM, year    0.417    0.741 
 ≤5 years 50.2 (12,171) 49.9 (6,050) 50.5 (6,121)  50.5 (6,157) 50.3 (3,067) 50.7 (3,090)  
 5-10 years 25.0 (6,057) 24.9 (3,020) 25.0 (3,037)  24.5 (2,990) 24.4 (1,488) 24.6 (1,502)  
 >10 years 24.8 (6,022) 25.2 (3,055) 24.5 (2,967)  25.0 (3,051) 25.3 (1,544) 24.7 (1,507)  
History of hypertension 73.8 (17,885) 73.6 (8,930) 73.9 (8,955) 0.715 72.5 (8,847) 72.7 (4,437) 72.3 (4,410) 0.584 
Family history of diabetes mellitus    0.900    0.954 
 Yes 43.8 (10,615) 43.7 (5,301) 43.8 (5,314)  43.4 (5,297) 43.5 (2,656) 43.3 (2,641)  
 No 8.7 (2,102) 8.6 (1,043) 8.7 (1,059)  7.7 (938) 7.6 (466) 7.7 (472)  
 Unknown 47.6 (11,533) 47.7 (5,781) 47.4 (5,752)  48.9 (5,963) 48.8 (2,977) 49.0 (2,986)  
Insulin used 1.6 (389) 1.7 (207) 1.5 (182) 0.201 1.9 (236) 1.8 (111) 2.0 (125) 0.357 
Enrolment of co-intervention 10.2 (2,473) 10.2 (1,233) 10.2 (1,240) 0.882 9.7 (1,185) 9.6 (588) 9.8 (597) 0.783 
 PEP Participants vs non-PEP Participants PEP Completers vs non-PEP Participants 
Factor Total 
(N=24,250) 
% (N) 
PEP (N=12,125) 
% (N) 
Non-PEP 
(N=12,125) 
% (N) 
P-value Total 
(N=12,198) 
% (N) 
PEP (N=6,099) 
% (N) 
Non-PEP 
(N=6,099) 
% (N) 
P-value 
on/before baseline 
History of macrovascular events 
on/before baseline 
5.6 (1,353) 5.6 (676) 5.6 (677) 0.978 5.8 (706) 5.7 (350) 5.8 (356) 0.816 
History of microvascular events 
on/before baseline 
6.6 (1,608) 6.6 (800) 6.7 (808) 0.836 6.0 (727) 6.1 (371) 5.8 (356) 0.566 
Number of severe hypoglycemic 
events on/before baseline 
   0.960    0.540 
 0 99.7 (24,166) 99.7 (12,084) 99.6 (12,082)  99.7 (12,158) 99.7 (6,080) 99.7 (6,078)  
 1 0.3 (69) 0.3 (34) 0.3 (35)  0.3 (39) 0.3 (18) 0.3 (21)  
 ≥2 0.1 (15) 0.1 (7) 0.1 (8)   0.0 (1) 0.0 (1) 0.0 (0)   
Note:         
PEP=Patient Empowerment Programme; BMI=Body mass index; HDL=High-density lipoprotein; TC=Total cholesterol; LDL=Low-density lipoprotein;   
eGFR=estimated Glomerular Filtration Rate ; T2DM=Type 2 Diabetes Mellitus;       
* p-value<0.05         
 
Table 2. Number and incidence rate of episodes of all-cause hospitalization and emergency department visit 
     
               
Number 
of cases 
Initial episode of event during the period   Frequency of episode event during the period 
 
Total 
PYs 
Median 
follow-up 
period 
(Months) 
Cumulative incidence Incidence rate 
 Total 
PYs 
Number of 
events 
Incidence rate 
Event 
Cases with 
event 
Rate 
Cases/ 100 
PYs 
95% CI*   
Cases/ 100 
PYs 
95% CI* 
Total (N=24,250)                         
All-cause hospitalization 24,250  54,843  30.5 5,733 0.2364 10.454 (10.185,10.728) 
 
61,801  11,390 18.430 (18.093,18.772) 
Emergency department visit 24,250  47,251  26.5 10,244 0.4224 21.680 (21.262,22.104) 
 
61,801  23,662 38.287 (37.801,38.778) 
PEP Participants (N=12,125) 
           
All-cause hospitalization 12,125  27,625  27.5 2,679 0.2209 9.698 (9.334,10.072) 
 
30,916  5,218 16.878 (16.423,17.342) 
Emergency department visit 12,125  23,882  25.5 4,909 0.4049 20.555 (19.984,21.138) 
 
30,916  11,177 36.153 (35.486,36.829) 
Non-PEP Participants (N=12,125) 
           
All-cause hospitalization 12,125  27,217  30.5 3,054 0.2519 11.221 (10.826,11.626) 
 
30,885  6,172 19.984 (19.488,20.489) 
Emergency department visit 12,125  23,369  29.5 5,335 0.4400 22.829 (22.221,23.450)   30,885  12,485 40.424 (39.718,41.139) 
Note: 
            PEP=Patient Empowerment Programme; PYs=Person-years; CI=Confidence interval 
       * The 95%CI was constructed based on Poisson Distribution 
          
Table 3. Multivariable analysis of the effect of PEP on the dependent variable of all-cause hospitalization and emergency department 
visit, adjusted for the socio-demographic and clinical characteristics 
                
 
Cox proportional hazard regression 
AIC BIC Harrell's C-statistic 
Initial episode of event during the period HR† se 95%CI P-value 
PEP Participants vs non-PEP Participants (N=24,250) 
     
All-cause hospitalization 0.879 0.024 (0.834,0.926) <0.001* 111,064 111,266 0.648 (0.640,0.655) 
Emergency department visit 0.901 0.018 (0.867,0.937) <0.001* 199,093 199,295 0.573 (0.567,0.579) 
Sensitivity Analysis, PEP Completers vs non-PEP Participants (N=12,198)         
All-cause hospitalization 0.835 0.033 (0.773,0.901) <0.001* 48,838 49,023 0.655 (0.644,0.666) 
Emergency department visit 0.890 0.025 (0.842,0.942) <0.001* 90,832 91,017 0.577 (0.568,0.585) 
 
Negative binomial regression 
AIC BIC 
Likelihood test with 
null model Frequency of episode event during the period IRR‡ se 95%CI P-value 
PEP Participants vs non-PEP Participants 
(N=24,250)        
All-cause hospitalization 0.854 0.034 (0.789,0.924) <0.001* 56,310 56,529 1293.96* 
Emergency department visit 0.903 0.020 (0.864,0.944) <0.001* 65,549 65,767 697.88* 
Sensitivity Analysis, PEP Completers vs non-PEP Participants (N=12,198)         
All-cause hospitalization 0.754 0.044 (0.672,0.846) <0.001* 26,880 27,080 639.94* 
Emergency department visit 0.857 0.028 (0.805,0.913) <0.001* 32,170 32,370 386.16* 
Note: 
       
HR=Hazard Ratio; se=Standard error; AIC=Akaike information criterion; BIC=Bayesian information criterion; IRR=Incidence rate 
ratio 
* p-value<0.05 
     
† HR>1 indicates greater risk for initial episode of event 
     
‡ IRR>1 indicates greater risk for episodes of event      
 

